These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15636223)

  • 1. [Proteinases inhibitors in sera of diabetic patients with non-proliferative retinopathy].
    Skopiński P; Duda-Król B; Lipińska A; Sommer E; Borowska A; Filewska M; Szaflik J; Skopińska-Rózewska E; Struzik E
    Klin Oczna; 2004; 106(3 Suppl):424-6. PubMed ID: 15636223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Angiogenic activity and VEGF level in sera of diabetic patients with non-proliferative retinopathy].
    Skopiński P; Duda-Król B; Lipińska A; Sommer E; Chorostowska-Wynimko J; Demkow U; Szaflik J; Skopińska-Rózewska E; Struzik E
    Klin Oczna; 2004; 106(3 Suppl):421-3. PubMed ID: 15636222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro angiomodulatory activity of sera from type 2 diabetic patients with background retinopathy.
    Chorostowska-Wynimko J; Skopiński P; Szaflik J; Partyka I; Duda-Król B; Anuszewska E; Skopińska-Rózewska E
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():65-70. PubMed ID: 16204777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone.
    Skopinski P; Szaflik J; Duda-Król B; Nartowska J; Sommer E; Chorostowska-Wynimko J; Demkow U; Skopinska-Rózewska E
    Int J Mol Med; 2004 Oct; 14(4):707-11. PubMed ID: 15375605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme activity and angiomodulatory effects of sera in patients with diabetic retinopathy.
    Skopiński P; Sommer E; Borowska A; Hevelke A; Rogala E; Skopińska-Rózewska E
    Int J Clin Pharmacol Res; 2001; 21(2):73-8. PubMed ID: 11824650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
    Lee IG; Chae SL; Kim JC
    Eye (Lond); 2006 May; 20(5):546-52. PubMed ID: 15905870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impaired antiendotoxin immunity in patients with diabetic retinopathy and type 2 diabetes mellitus].
    Zhaboedov GD; Kopaenko AI
    Vestn Oftalmol; 2005; 121(6):29-31. PubMed ID: 16405060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.
    Muller LM; Gorter KJ; Hak E; Goudzwaard WL; Schellevis FG; Hoepelman AI; Rutten GE
    Clin Infect Dis; 2005 Aug; 41(3):281-8. PubMed ID: 16007521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H; Shi CH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A; Bianchi E; Reali GL; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parameters of blood proteinase inhibitor balance and hyperlipoproteinemia in patients with proliferative diabetic retinopathy with vitreous hemorrhage].
    Chesnokova NB; Kuznetsova TP; Davydova GA; Grigor'ev AV
    Vestn Oftalmol; 1999; 115(6):29-32. PubMed ID: 10665286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed angiogenic activity in sera from obstructive sleep apnea patients.
    Chorostowska-Wynimko J; Radomska D; Pływaczewski R; Jończak L; Stepniewska A; Górecka D; Skopińska-Rózewska E
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():71-7. PubMed ID: 16204778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.
    Jacqueminet S; Ben Abdesselam O; Chapman MJ; Nicolay N; Foglietti MJ; Grimaldi A; Beaudeux JL
    Clin Chim Acta; 2006 May; 367(1-2):103-7. PubMed ID: 16426593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma prekallikrein as a risk factor for diabetic retinopathy.
    Kedzierska K; Ciechanowski K; Gołembiewska E; Safranow K; Ciechanowicz A; Domański L; Myślak M; Róźański J
    Arch Med Res; 2005; 36(5):539-43. PubMed ID: 16099335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.
    Dave GS; Kalia K
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):68-78. PubMed ID: 17543235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic activity of sera from silicosis and pulmonary Langerhans cell histiocytosis patients in relation to lung function tests.
    Zielonka TM; Demkow U; Filewska M; Bialas-Chromiec B; Zycinska K; Radzikowska E; Korzeniewska M; Wardyn KA; Kus J; Skopinska-Rozewska E
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():781-9. PubMed ID: 19218705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endothelium and diabetes: study of plasma levels of endothelin-1 in diabetic patients with arterial hypertension or proliferative retinopathy].
    Parlapiano C; Paoletti V; Campana E; Rota C; Donnarumma L; Musca A; Andreani D
    Minerva Med; 1995 Mar; 86(3):105-20. PubMed ID: 7603606
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multivariate analysis for the understanding of typical diabetic hemostasis criteria. 1: Plasma markers].
    Syrbe G; Schröder H; Keil E; Jütte A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):717-23. PubMed ID: 1709905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interleukin-12, vascular endothelial growth factor and tumor necrosis factor-alpha in the process of neoangiogenesis of diabetic retinopathy in children].
    Zorena K; Myśliwska J; Myśliwiec M; Balcerska A; Lipowski P; Raczyńska K
    Klin Oczna; 2007; 109(4-6):155-9. PubMed ID: 17725275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.